Publications by authors named "Sarah Keppner"

Claim this Profile
D
Drugs by numbers: reaction-driven de novo design of potent and selective anticancer leads.
Birgit Spänkuch, Sarah Keppner, Lisa Lange, Tiago Rodrigues, Heiko Zettl

Angew Chem Int Ed Engl· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reaction-driven de novo design, synthesis and testing of potential type II kinase inhibitors.
Gisbert Schneider, Tim Geppert, Markus Hartenfeller, Felix Reisen, Alexander Klenner, Sarah Keppner

Future Med Chem· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fate of primary cells at the G₁/S boundary after polo-like kinase 1 inhibition by SBE13.
Sarah Keppner, Ewgenij Proschak, Gisbert Schneider, Birgit Spänkuch

Cell Cycle· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polo-like kinase 1 as predictive marker and therapeutic target for radiotherapy in rectal cancer.
Franz Rödel, Sarah Keppner, Gianni Capalbo, Robina Bashary, Manfred Kaufmann

Am J Pathol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological impact of freezing Plk1 in its inactive conformation in cancer cells.
Sarah Keppner, Ewgenij Proschak, Manfred Kaufmann, Klaus Strebhardt, Gisbert Schneider

Cell Cycle· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and validation of a potent type II inhibitor of inactive polo-like kinase 1.
Sarah Keppner, Ewgenij Proschak, Gisbert Schneider, Birgit Spänkuch

ChemMedChem· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis